COMMUNIQUÉS West-GlobeNewswire

Symbiotic.blue Launches to Combine Oxford and Cambridge Scientific Brain Power with Bioentrepreneurial Leadership to Reinvent AI Drug Discovery
19/06/2025
LONDON, June 19, 2025 (GLOBE NEWSWIRE) -- Symbiotic.blue, the UK’s newest Techbio company has launched to innovate a next-generation artificial intelligence-driven drug discovery (AIDD) platform by combining the power [...]
Verano Announces Exclusive Partnership with Award-Winning Arizona Cannabis Operator Grow Sciences to Bring its Best-In-Class Products to Illinois
19/06/2025
Grow Sciences flower, pre-rolls, solventless extracts, vaporizers and edibles will initially be sold exclusively at Zen Leaf dispensaries in the Illinois market CHICAGO, June 19, 2025 (GLOBE NEWSWIRE) -- Verano Holdings [...]
Catholic Health Teams Up with Olympic Gold Medalist Katie Ledecky to Help Patients Optimize Their Health
19/06/2025
As Health & Wellness Ambassador at Catholic Health, Ledecky channels her Olympic mindset to educate Long Islanders ROCKVILLE CENTRE, N.Y., June 19, 2025 (GLOBE NEWSWIRE) -- Catholic Health is teaming up with nine- [...]
Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
19/06/2025
Strong cash position of CHF2.8 million at end of Q1 2025 GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to our phase 2 mGlu2 PAM asset, ADX71149 Indivior [...]
VIRBAC: Paul Martingell nommé directeur général du groupe Virbac au 1er septembre 2025
19/06/2025
Virbac annonce la nomination de Paul Martingell en tant que directeur général du groupe Virbac à compter du 1 er septembre 2025. Paul Martingell, 45 ans, est un leader reconnu qui a démontré sa capacité à fédérer des [...]
VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025
19/06/2025
Virbac announces the appointment of Paul Martingell as the chief executive officer of the Virbac group, effective September 1, 2025. Paul Martingell, 45, is recognized as a leader who has demonstrated his ability to [...]
Major shareholder announcement
19/06/2025
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and [...]
CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells
19/06/2025
In-vitro lab results confirmed that the Company’s cell targeting nanoparticles successfully entered cancer cells and avoided non-cancerous cells Lehi, June 19, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 19, 2025 – [...]
HLTH Inc. Unveils HLTH.rad — A Bold New Global Gathering for Imaging Innovators Co-Located with HLTH Europe 2026 in Amsterdam
19/06/2025
AMSTERDAM, Netherlands, June 19, 2025 (GLOBE NEWSWIRE) -- HLTH Inc., the leading global platform for health innovation, is proud to announce the launch of HLTH.rad, a groundbreaking new event that will redefine the [...]
OnlineSemaglutide.org Launches Platform Offering Easy Access to GLP-1 Medications
18/06/2025
Revolutionizing Access to Modern Weight-Care Solutions San Diego, CA, June 18, 2025 (GLOBE NEWSWIRE) -- OnlineSemaglutide.org, a leader in the field of Health & Medicine, Women's Health, and Men's Health, is [...]
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
18/06/2025
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused with fresh CAR-T cells, and 93% were treated within seven days of manufacturing GLPG5101 demonstrated [...]
Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal
18/06/2025
Failure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholders SAN MATEO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced [...]
Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA)
18/06/2025
Dr. Clark Brings 25 Years of Experience Treating Retina Diseases and Developing Emerging Therapies as a Principal Investigator in Over 70 Clinical Trials and as an Early Pioneer of VEGF Inhibitors ANX007 is the Only [...]
Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split
18/06/2025
FLORHAM PARK, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of [...]
BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs
18/06/2025
LOUISVILLE, Ky., June 18, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud to announce that its specialty pharmacy, Onco360® , has been [...]
Kane Biotech Provides Further Corporate Update
18/06/2025
WINNIPEG, Manitoba, June 18, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) provides updates on its reorganizational phase. The Company has terminated its exclusive [...]
Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering
18/06/2025
New Taipei City, Taiwan, June 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative [...]
PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares
18/06/2025
TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“ Psyence ” or the “ Company ”), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and [...]
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
18/06/2025
Company announcement – No. 15 / 2025 Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Body weight reductions of a mean of 11.6% after 28 [...]

Pages